Results 131 to 140 of about 944,744 (294)

Cancer vaccines: uses of HLA transgenic mice compared to genetically modified mice [PDF]

, 2008
Many tumor antigens have been identified that can be targeted by the immune system. Animal models that have been genetically modified to express human HLA molecules instead of their own MHC antigens have shown to be valuable in the discovery of peptides ...
McArdle, SE
core  

Gut microbiome influences efficacy of PD-1–based immunotherapy against epithelial tumors

Science, 2018
B. Routy, E. Le Chatelier, L. Derosa, Connie P. M. Duong, M. Alou, Romain Daillère, A. Fluckiger, M. Messaoudene, C. Rauber, M. Roberti, Marine Fidelle, C. Flament, V. poirier-colame, P. Opolon, C. Klein, Kristina Iribarren, L. Mondragón, N. Jacquelot, B. Qu, Gladys Ferrere, C. Clémenson, L. Mezquita, J. R. Masip, C. Naltet, S. Brosseau, C. Kaderbhai, C. Richard, H. Rizvi, F. Levenez, N. Galleron, B. Quinquis, N. Pons, B. Ryffel, V. Minard-Colin, P. Gonin, J. Soria, E. Deutsch, Y. Loriot, F. Ghiringhelli, G. Zalcman, F. Goldwasser, B. Escudier, M. Hellmann, A. Eggermont, D. Raoult, L. Albiges, G. Kroemer, L. Zitvogel   +47 more
semanticscholar   +1 more source

Specific immunotherapy in Albanian patients with anaphylaxis to hymenoptera venoms [PDF]

, 2002
Background: Severe allergic reactions during rush-specific immunotherapy (Rush-SIT) may occur in the treatment of hymenoptera sting allergy. The objective of the present study was to examine the characteristics of allergic reactions during Rush-SIT in a ...
Dinh, Q. Thai, Fischer, Axel, Groneberg, Jan David Alexander, Mingomataj, Ervin, Peiser, Christian, Priftanji, Alfred, Qirko, Etleva   +6 more
core  

Cancer immunotherapy using checkpoint blockade

Science, 2018
A. Ribas, J. Wolchok
semanticscholar   +1 more source

Tumor regression at an untreated site during immunotherapy of an identical distant tumor. [PDF]

, 1975
Seymour I. Schlager, S Dray
openalex   +1 more source

Gut microbiome modulates response to anti–PD-1 immunotherapy in melanoma patients

Science, 2018
V. Gopalakrishnan, C. Spencer, L. Nezi, A. Reuben, M. Andrews, T. Karpinets, P. Prieto, D. Vicente, K. Hoffman, S. Wei, Alexandria P. Cogdill, L. Zhao, C. Hudgens, D. Hutchinson, T. Manzo, M. Petaccia de Macedo, T. Cotechini, T. Kumar, W. Chen, S. Reddy, R. S. Szczepaniak Sloane, J. Galloway-Peña, H. Jiang, P. Chen, E. Shpall, K. Rezvani, A. Alousi, R. Chemaly, S. Shelburne, L. Vence, P. Okhuysen, V. B. Jensen, A. Swennes, F. McAllister, E. Marcelo Riquelme Sanchez, Y. Zhang, E. Le Chatelier, L. Zitvogel, N. Pons, J. Austin-Breneman, L. Haydu, E. Burton, J. Gardner, E. Sirmans, J. Hu, A. Lazar, T. Tsujikawa, A. Diab, H. Tawbi, I. Glitza, W. Hwu, S. Patel, S. Woodman, R. Amaria, M. Davies, J. Gershenwald, P. Hwu, J. Lee, J. Zhang, L. Coussens, Z. Cooper, P. Futreal, C. Daniel, N. Ajami, J. Petrosino, M. Tetzlaff, P. Sharma, J. Allison, R. Jenq, J. Wargo   +69 more
semanticscholar   +1 more source

THE IMMUNOTHERAPY OF ACUTE MYELOGENOUS LEUKAEMIA USING INTRAVENOUS BCG [PDF]

, 1977
J. A. Whiitaker, A. J. Slater
openalex   +1 more source

Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy

Cell, 2017
Padmanee Sharma, S. Hu-Lieskovan, J. Wargo, A. Ribas   +3 more
semanticscholar   +1 more source

Complete remissions following immunotherapy or immuno-oncology combinations in cancer patients: the MOUSEION-03 meta-analysis

Cancer Immunology and Immunotherapy, 2023
M. Santoni, Alessandro Rizzo, J. Kucharz, V. Mollica, M. Rosellini, Andrea Marchetti, Elisa Tassinari, F. Monteiro, A. Soares, J. Molina-Cerrillo, E. Grande, N. Battelli, F. Massari   +12 more
semanticscholar   +1 more source

IMMUNOTHERAPY

HemaSphere, 2022
openaire   +2 more sources